Tuberculosis

Showing NaN - NaN of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV, Tuberculosis, Diabetes Trial in Johannesburg (Minimum package of interventions to improve ART adherence)

Completed
  • HIV
  • +3 more
  • Minimum package of interventions to improve ART adherence
  • Johannesburg, South Africa
    Johannesburg Site
Jul 29, 2019

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
  • Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

HIV-1 Infection, Tuberculosis Trial in Worldwide (Depot medroxyprogesterone acetate)

Completed
  • HIV-1 Infection
  • Tuberculosis
  • Depot medroxyprogesterone acetate
  • Gaborone, Botswana
  • +4 more
Jun 13, 2019

Influenza, HIV, Tuberculosis Trial in Johannesburg (Trivalent Inactivated Influenza Vaccine)

Completed
  • Influenza
  • +2 more
  • Trivalent Inactivated Influenza Vaccine
  • Johannesburg, Gauteng, South Africa
    Respiratory and Meningeal Pathogens research unit
Sep 3, 2018

Tuberculosis Trial in Cape Town, Johannesburg (VPM1002, BCG, VPM1002(Hyg+))

Completed
  • Tuberculosis
  • VPM1002
  • +2 more
  • Cape Town, South Africa
  • +3 more
Apr 17, 2018

Tuberculosis Trial in Johannesburg, Cape Town, Worcester (AERAS-404, Placebo)

Completed
  • Tuberculosis
  • AERAS-404
  • Placebo
  • Johannesburg, Guateng, South Africa
  • +3 more
Apr 6, 2018

HIV Infection, Tuberculosis Trial in Worldwide (Standard-dose Lopinavir/Ritonavir, Double-dose Lopinavir/Ritonavir, Raltegravir)

Terminated
  • HIV Infection
  • Tuberculosis
  • Standard-dose Lopinavir/Ritonavir
  • +8 more
  • Porto Alegre, RS, Brazil
  • +8 more
Feb 7, 2018

Diagnostics in HIV-Infected Individuals

Completed
  • HIV Infections
  • Tuberculosis
  • Standardized diagnostic evaluation
  • Gaborone, Botswana
  • +12 more
Mar 17, 2015